Literature DB >> 4702182

Levodopa for parkinsonism in elderly and demented patients.

G A Broe, F I Caird.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4702182     DOI: 10.5694/j.1326-5377.1973.tb110594.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  5 in total

Review 1.  Newer aspects of drug therapy in the elderly.

Authors:  F I Caird
Journal:  Klin Wochenschr       Date:  1990-06-19

2.  Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia.

Authors:  S G Bowes; P K Clark; A Charlett; C J O'Neill; A L Leeman; C Weller; P W Nicholson; A A Deshmukh; S M Dobbs; R J Dobbs
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

3.  The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.

Authors:  D R Robertson; N D Wood; H Everest; K Monks; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

4.  Systemic activity of orally administered L-dopa in the elderly Parkinson patient.

Authors:  M A Evans; E J Triggs; G A Broe; N Saines
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

5.  Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.

Authors:  Chukwuemeka S Okereke; Louis Kirby; Dinesh Kumar; Edward I Cullen; Raymond D Pratt; William A Hahne
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.